Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

296.87B

Market cap296.87B

Price-Earnings ratio

33.66

Price-Earnings ratio33.66

Dividend yield

2.78%

Dividend yield2.78%

Average volume

13.11M

Average volume13.11M

High today

$121.81

High today$121.81

Low today

$119.12

Low today$119.12

Open price

$120.90

Open price$120.90

Volume

2.65M

Volume2.65M

52 Week high

$125.14

52 Week high$125.14

52 Week low

$76.66

52 Week low$76.66

Stock Snapshot

With a market cap of 296.87B, Merck(MRK) trades at $120.20. The stock has a price-to-earnings ratio of 33.66 and currently yields dividends of 2.78%.

As of 2026-06-24, Merck(MRK) stock has fluctuated between $119.12 and $121.81. The current price stands at $120.20, placing the stock +0.9% above today's low and -1.3% off the high.

The Merck(MRK)'s current trading volume is 2.65M, compared to an average daily volume of 13.11M.

In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.

MRK News

TipRanks 5h

Merck says EC approves Keytruda plus Padcev combination

Merck (MRK) announced that Keytruda, Merck’s anti-PD-1 therapy, in combination with Padcev, an antibody-drug conjugate, is approved in the European Union, as ne...

Simply Wall St 1d

Merck Stock Could Be 11% Undervalued After June Pipeline Wins

Merck (MRK) stock is drawing fresh attention after a cluster of June 2026 pipeline milestones, including new FDA approvals for KEYTRUDA plus WELIREG and CAPVAXI...

MarketWatch 2d

Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Analyst ratings

71%

of 31 ratings

Buy

71%

Hold

29%

Sell

More MRK News

Benzinga 2d

Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy

Positive Data For Tulisokibart In Ulcerative Colitis The company announced that the Phase 3 ATLAS-UC induction-only study, also known as Study 2, met its prima...

Benzinga 6d

FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

The decision makes Capvaxive the only pneumococcal conjugate vaccine specifically studied and indicated in the U.S. for this patient group. Phase 3 STRIDE-13 d...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

Ecolab

Cognex

WisdomTree Japan Hedged E…

Baker Hughes Company

Colgate

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.